stoxline Quote Chart Rank Option Currency Glossary
  
agilon health, inc. (AGL)
2.09  -0.02 (-0.95%)    11-29 13:00
Open: 2.11
High: 2.21
Volume: 2,835,469
  
Pre. Close: 2.11
Low: 2.09
Market Cap: 861(M)
Technical analysis
2024-11-29 1:50:32 PM
Short term     
Mid term     
Targets 6-month :  2.95 1-year :  3.69
Resists First :  2.52 Second :  3.16
Pivot price 1.87
Supports First :  1.5 Second :  1.24
MAs MA(5) :  2.08 MA(20) :  2.09
MA(100) :  4 MA(250) :  5.75
MACD MACD :  -0.3 Signal :  -0.4
%K %D K(14,3) :  51.7 D(3) :  42.2
RSI RSI(14): 46.4
52-week High :  13.76 Low :  1.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ AGL ] has closed below upper band by 21.1%. Bollinger Bands are 43.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.19 - 2.2 2.2 - 2.21
Low: 2.02 - 2.03 2.03 - 2.04
Close: 2.09 - 2.11 2.11 - 2.12
Company Description

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Headline News

Sat, 30 Nov 2024
Citigroup Inc. Has $7.97 Million Stake in agilon health, inc. (NYSE:AGL) - MarketBeat

Sat, 30 Nov 2024
agilon health, inc. (NYSE:AGL) Given Average Rating of "Reduce" by Brokerages - MarketBeat

Mon, 25 Nov 2024
Agilon Health's SWOT analysis: stock faces challenges amid value-based care growth - Investing.com

Sun, 10 Nov 2024
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Fri, 08 Nov 2024
agilon health Plunges On A Poor Prognosis (Rating Downgrade) (NYSE:AGL) - Seeking Alpha

Thu, 07 Nov 2024
Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 412 (M)
Shares Float 306 (M)
Held by Insiders 1.7 (%)
Held by Institutions 105 (%)
Shares Short 36,220 (K)
Shares Short P.Month 36,490 (K)
Stock Financials
EPS -0.76
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.38
Profit Margin -6.9 %
Operating Margin -9.2 %
Return on Assets (ttm) -9.9 %
Return on Equity (ttm) -43 %
Qtrly Rev. Growth 27.6 %
Gross Profit (p.s.) 0
Sales Per Share 13.56
EBITDA (p.s.) -0.78
Qtrly Earnings Growth 0 %
Operating Cash Flow -135 (M)
Levered Free Cash Flow -90 (M)
Stock Valuations
PE Ratio -2.8
PEG Ratio 0
Price to Book value 1.52
Price to Sales 0.15
Price to Cash Flow -6.47
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android